相关实验视频
Updated: May 7, 2025
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.5K
过多的Ub-K48诱导阿尔茨海默氏症疾病中神经元亡
Qiang Li1, Yiyuan Yuan2, Shi Huang2
1Human Anatomy Experimental Training Center, School of Basic Medical Sciences, Wannan Medical College, 241002 Wuhu, Anhui, China.
Journal of integrative neuroscience
|December 30, 2024
概括
与K48结合的泛素链 (Ub-K48) 与阿尔茨海默病 (AD) 的发展有关. 这项研究表明,在AD神经元中Ub-K48和p-Tau的局部化,诱导细胞亡和炎症.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 与K48结合的泛素链 (Ub-K48) 是蛋白质降解的关键.
- 在阿尔茨海默病 (AD) 病原和神经元亡中Ub-K48的作用尚未完全理解.
研究的目的:
- 为了研究K48在AD病因学中的功能.
- 阐明AD中神经元亡的潜在机制.
主要方法:
- 构建了一个AD小鼠模型,并使用开放现场测试评估行为变化.
- 分析了状纤维酸蛋白 (GFAP),酸化 (p-Tau),Ub-K48,Bcl-2和巴克斯的表达方式.
- 通过HE,Nissl染色,免疫组织化学和免疫光学,评估了神经元亡和海马中的p-Tau/Ub-K48同位化.
主要成果:
- 阿尔茨海默病小鼠表现出认知障碍,GFAP表达增加和海马神经元异常.
- 在AD神经元中观察到高的p-Tau和Ub-K48水平,具有显著的局部化.
- 巴克斯的升高和BCL-2/巴克斯比率的降低表明AD神经元细胞的诱导性亡.
结论:
- K48的无处不在与AD发展密切相关.
- 在AD神经元中p-Tau聚合物和Ub-K48的局部化会触发细胞炎症和亡.
相关概念视频
01:26Alzheimer's Disease: Overview
311
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
311
01:22Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125